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Background. Chronic respiratory symptoms are common among children living with human immunodeficiency virus (HIV). 
We investigated the radiological features of chronic lung disease in children aged 6–16 years receiving antiretroviral therapy for 
≥6 months in Harare, Zimbabwe.
Methods. Consecutive participants from a HIV clinic underwent clinical assessment and chest radiography. Participants with an 
abnormal chest radiograph (assessed by a clinician) and/or those meeting a clinical case definition for chronic lung disease under-
went high-resolution computed tomography (HRCT). Radiological studies were scored independently and blindly by 2 thoracic 
radiologists. Relationships between radiological abnormalities and lung function were examined.
Results. Among 193 participants (46% female; median age, 11.2 years; interquartile range, 9.0–12.8 years), the median CD4 cell 
count was 720/µL (473–947/µL), and 79% had a human immunodeficiency virus (HIV) load of <400 copies/mL. The most common 
chest radiographic finding was ring/tramline opacities (55 of 193 participants; 29%). HRCT scans were evaluated in 84 participants 
(69%); decreased attenuation (present in 43%) was the dominant abnormality seen. The extent of decreased attenuation was strongly 
correlated with both the severity and extent of bronchiectasis (rs = 0.68 and P < .001 for both). The extent of decreased attenua-
tion was also negatively correlated with forced expiratory volume in first second of expiration (rs = –0.52), forced vital capacity 
(rs = –0.42), and forced expiratory flow, midexpiratory phase (rs = –0.42) (P < .001 for all).
Conclusions. The HRCT findings strongly suggest that obliterative bronchiolitis may be the major cause of chronic lung disease 
in our cohort. Further studies to understand the pathogenesis and natural history are urgently needed.
Keywords. Sub-Saharan Africa; HIV; chronic lung disease; HRCT; chest X-ray. 
The global scale-up of antiretroviral therapy (ART) has resulted 
in a substantial decline in the incidence of perinatally acquired 
infections, and in a dramatic improvement in survival of chil-
dren with human immunodeficiency virus (HIV) infection [1]. 
Hence, children with HIV who would otherwise have died in 
infancy, are now reaching adolescence in large numbers, and the 
pediatric HIV epidemic has shifted from one characterized by 
very high early childhood mortality rates to one that is a chronic, 
treatable condition among older children and adolescents [2].
Cotrimoxazole prophylaxis and ART substantially reduce the 
risk of acute respiratory tract infections and tuberculosis [3, 4]. 
However, recent studies from sub-Saharan Africa have reported 
a high prevalence of chronic lung disease, even among older 
children receiving ART [5–7]. The typical clinical picture is of 
a chronic, usually nonproductive, cough, hypoxia, tachypnea, 
reduced exercise tolerance and decreased lung function, and 
“nonspecific” chest radiographic abnormalities [8]. Plain chest 
radiography, despite its ready availability, is insensitive, and ter-
minology used to define abnormalities often inconsistent. The 
limited availability of diagnostic modalities in resource-limited 
settings hinders definitive diagnosis and, in the absence of an 
alternative diagnoses, presumptive tuberculosis treatment is 
often started for those with chronic respiratory symptoms [9].
We recently conducted a prospective study to investigate the 
prevalence of chronic respiratory disease in HIV-infected chil-
dren and adolescents attending for routine HIV care who were 
well established on ART and receiving cotrimoxazole proph-
ylaxis. Among these children, 25% had chronic respiratory 
symptoms and reduced lung function [10]. In the present study, 
we report the spectrum of abnormalities on high-resolution 
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computed tomography (HRCT) among study participants and 
association of radiological abnormalities with lung function.
METHODS
Study Participants
HIV-infected children aged 6–16  years receiving routine out-
patient HIV care at the Harare Central Hospital, the largest 
public-sector hospital in Harare, Zimbabwe, were consecutively 
recruited, with enrollment limited to the first 5 eligible children 
every weekday for logistical ease. Recruitment was limited to 
those receiving ART (first or second line) for ≥6 months. The 
6-month cutoff for ART duration was selected to allow enough 
time for participants to achieve viral suppression and for 
immune reconstitution inflammatory syndrome to manifest, 
which usually occurs in the first few months after ART initi-
ation. Children with tuberculosis (excluded through sputum 
smear and culture examination) or presenting with symptoms 
and signs of acute respiratory tract infection were excluded.
The study was approved by the Medical Research Council 
of Zimbabwe, the Harare Hospital Ethics Committee, the 
Biomedical Research and Training Institute Institutional Review 
Board, and the London School of Hygiene and Tropical Medicine 
Ethics Committee. Written informed consent from guardians 
and assent from children was obtained before enrollment.
Data Collection
Study procedures are described in detail elsewhere [10]. Briefly, 
sociodemographic and clinical data including HIV treatment 
history, past illnesses, and current symptoms were collected 
through a nurse-administered questionnaire. Participants 
underwent a standardized clinical examination, including pulse 
oximetry, shuttle walk testing, and spirometry. Spirometry was 
performed using EasyOne World spirometers (ndd Medical 
Technologies), following American Thoracic Society stand-
ard procedures [11]. Up to 8 forced exhalations were recorded 
with patients sitting, and the only data analyzed were from indi-
viduals who produced 3 consistent traces that met American 
Thoracic Society quality criteria. The highest forced expiratory 
volume in first second of expiration (FEV1) and forced vital 
capacity measurements were used, with other indices recorded 
from the best trace (largest total of FEV1 and forced vital capac-
ity). Normal spirometric ranges were defined using the GLI 2012 
equation, which gives reference values specific for race and sex 
and takes into account height and age [12]. The lower limit of 
normal was defined as 1.64 standard deviations (SDs) below the 
mean expected value (which describes the lowest 10 centiles of 
the reference population as “abnormal”). CD4 cell counts were 
determined using the PIMA platform (Alere), and HIV load by 
means of the COBAS Ampliprep/Taqman 48 analyzer (Roche).
Study participants underwent standard posteroanterior plain 
chest radiography. Participants referred for HRCT of the chest 
included those with an abnormal chest radiograph (assessed 
initially by a respiratory physician, blinded to clinical data) 
and those meeting the clinical case definition of chronic lung 
disease (ie, the presence of ≥1 of the following: chronic cough 
for ≥1 month with no microbiological evidence of tuberculosis; 
oxygen saturation of <92% at rest or desaturation of ≥5% from 
baseline on exercise testing; Medical Research Council (MRC) 
dyspnea score of >1; resting tachypnea [respiratory >30/min for 
6–12-year-olds or >24/min for 13–16-year-olds); and abnormal 
results of spirometry, as defined above.
Supine HRCT images (1-mm collimation with 10-mm inter-
spacing) were acquired at full inspiration and reconstructed 
using a high-spatial-frequency lung algorithm with window 
settings appropriate for viewing the lung parenchyma (window 
centre, −550 HU; window width, 1500 HU). HRCT studies were 
anonymized and downloaded onto digital storage disks for sub-
sequent review on high-resolution screens using an Osirix HD 
viewing platform (OsiriX, version 6.5.2; OsiriX Foundation). The 
chest radiographic and HRCT studies were scored independently 
and in separate sessions by 2 thoracic radiologists blinded to clin-
ical data (S. R. D. and A. N., with 20 and 11 years’ experience 
respectively in the interpretation of thoracic imaging).
Chest Radiographic and HRCT Scoring
Principal chest radiographic and HRCT patterns were defined 
according to the Fleischner Society Glossary of terms [13]. Chest 
radiographic abnormalities were quantified using a previously 
validated scoring system with low interobserver variability [14]. 
In brief, the overall extent of abnormal lung (irrespective of pat-
tern) was graded semiquantitatively on a 5-point scale (0, nor-
mal lung; 1–4, 1%–25%, 26%–50%, 51%–75%, and 76%–100% 
abnormal lung, respectively). The proportional extents of the 
following principal radiographic patterns were then quanti-
fied: consolidation; reticular pattern; noncavitating nodules; 
cavitating nodules; ring and/or tramline opacities (reflecting 
the presence of thick-walled and/or dilated bronchi seen either 
“end-on” [rings] or in plane [tramlines]; ground-glass opaci-
fication; and masses. Nonprincipal patterns—namely, paucity 
of vessels, hilar and/or mediastinal lymph node enlargement, 
and hyperexpansion—were recorded as absent or present. The 
severity of volume loss, if present, was graded semiquantita-
tively (0, no volume loss; 1, mild; 2, severe).
HRCT patterns were quantified visually in 6 lobes (note that 
the lingula was considered as a separate lobe). The lobar extent/
severity of the following HRCT abnormalities were scored sem-
iquantitatively [15, 16]: (1) the extent of bronchiectasis (0,  no 
bronchiectasis; 1, bronchiectasis in 1 or part of 1 bronchopul-
monary segment; 2,  bronchiectasis in >1 bronchopulmonary 
segment; and 3,  generalized bronchiectasis); (2) the severity 
of bronchiectasis (0, no airway dilatation; 0.5, trivial dilatation 
compared with the transverse diameter of the homologous pul-
monary artery; 1,  100%–200% of that diameter; and 2,  more 
than 200%–300% of that diameter); (3) the severity of bronchial 
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wall thickening (0,  no discernible wall thickening; 0.5,  triv-
ial wall thickening; 1,  <50% of the transverse diameter of the 
homologous pulmonary artery; 2, 50%–100% of the transverse 
diameter of the accompanying pulmonary artery); (4) the extent 
of centrilobular (small airway); (5) large-airway mucus plugging 
(both similarly scored as follows: 0, no plugging; 1, plugging in 1 
or part of 1 bronchopulmonary segment; 2, plugging in >1 bron-
chopulmonary segment; and 3, generalized plugging in all bron-
chopulmonary segments); (6) the severity of lobar volume loss 
(0, no volume loss; 1, mild volume loss; and 2, marked volume 
loss). Thus, the maximal expressible score for each of the extent 
of bronchiectasis, small-airway plugging, and large-airway plug-
ging was 18, and the maximal score for severity of bronchiecta-
sis, bronchial wall thickening and volume loss was 12.
After semiquantitative evaluation, the overall extent of 
abnormal lung in each lobe (to the nearest 5%) and the propor-
tional extents of the following HRCT patterns (totaling 100%) 
were quantified: consolidation, a reticular pattern, ground-glass 
opacification, decreased attenuation (as a component of the 
mosaic attenuation pattern), emphysema, and pulmonary air 
cysts and nodules, with or without cavitation. Discrepant obser-
vations for the presence or absence of the radiological patterns 
and their distribution were resolved by consensus review. The 
threshold for consensus was a difference in proportional extent 
of abnormalities of >20%.
Statistical Analysis
Data were extracted from paper-based questionnaires by optical 
character recognition (Cardiff Teleform Intelligent Character, 
version 10.7), and analyzed using Stata software (version 
12; (=StataCorp). Data were expressed as means  with SDs or 
medians with interquartile range (IQR) or range, as appropri-
ate. A  height-for-age and weight-for age z score of ≤2, based 
on World Health Organization reference standards, was used to 
define stunting and wasting, respectively [17]. For chest radiog-
raphy, the score for each pattern was recorded as a mean value 
of both observers’ scores. Similarly, for the 6 semiquantitatively 
scored HRCT abnormalities, the lobar scores for each observer 
were first summed, and the average for the 2 observers was then 
calculated. Because the maximal expressible scores for the sem-
iquantitative variables differed, the semiquantitative data were 
linearly transformed into a percentage scale, wherein 0 rep-
resented normal appearances, and 100 the maximal extent of 
abnormality, to homogenize the scores [18]. Thus, for example, 
a patient with a bronchiectasis extent score of 6 and a bronchi-
ectasis severity score of 6 would have his or her scores expressed 
as 6/18 × 100 = 33.3 and 6/12 × 100 = 50.0, respectively. 
For the total extent of abnormality and the proportional extent 
of the 8 CT patterns assessed, the post-consensus lobar scores 
for each observer were first summed, divided by 6 to obtain a 
mean lobar score, and the average lobar score for the 2 observers 
was then calculated. Observer agreement data for quantifying 
the extent/severity of chest radiographic and HRCT patterns was 
assessed using the weighted quadratic Cohen’s kappa value (κω) 
for ordinal variables or the single-determination (SD) [19] for 
continuous variables as appropriate. Agreement was categorized 
as poor (κω, 0 to ≤0.20), fair (0.20 to ≤0.40), moderate (0.40 to 
≤0.60), good (0.60 to ≤0.80), or excellent (0.80 to ≤1.00) [19]. 
The association between common HRCT patterns (>10% prev-
alence) and between HRCT patterns and FEV1 was examined 
using Spearman rank correlation coefficients (rs).
RESULTS
Of the 202 participants recruited into the study, 193 had chest 
radiographic data available; the median age of participants was 
11.2 years (IQR, 9.0–12.8) years, and 46% were female. The 
median duration of ART was 4.8 years (IQR, 2.6–6.4) and 79% 
had an HIV load <400 copies/mL. The chest radiograph was 
assessed as abnormal by the respiratory physician in 44% of 
participants and by the thoracic radiologists in 33% (64 of 193). 
The most common principal abnormality was ring/tramline 
opacities (seen in 28% of participants), followed by consolida-
tion (seen in 7%). Other patterns were uncommon (Table 1).
Overall, 121 participants (63%) were eligible for HRCT scan-
ning owing either to abnormal clinical findings or to an abnor-
mal chest radiograph (Figure 1). Of these, 89 (74%) underwent 
HRCT scanning (the remainder not attending for their appoint-
ment), of whom 5 were excluded because of image degradation 
by breathing artifact. Among those eligible for HRCT, there 
were no differences between those who did and those who did 
not undergo HRCT in age or sex, duration of ART, proportion 
with viral suppression, or proportion with respiratory symp-
toms and signs. Clinical findings are summarized in Table 2 but 
are discussed in detail elsewhere [10].
Table 1. Prevalence and Extent of Chest Radiographic Abnormalities
Abnormality
Participants, No. (%)
Prevalence of 
Abnormality
With >25% Extent of 
Abnormalitya
Principle patterns
 Rings or tramlines 55 (28) 54 (98)
 Consolidation 14 (7) 10 (71)
 Ground-glass pattern 10 (5) 7 (70)
 Reticulation 1 (0.5) 0 (0)
 Noncavitating nodules 3 (2) 3 (100)
 Cavitating nodules 0 …
 Mass 0 …
Nonprincipal patterns
 Volume loss 10 (5) NA
 Hyperexpansion 4 (2) NA
 Lymph nodes 8 (4) NA
 Paucity of markings 3 (2) NA
Abbreviation: NA, not applicable.
aGiven as a percentage of those exhibiting the abnormality.
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HRCT abnormalities were present in 70 of 84 participants 
(83%); the chest radiograph was normal in 39 participants (56%) 
with HRCT abnormalities. The most common HRCT abnormality 
was bronchial wall thickening, observed in 82% of HRCT scans, 
but this was of trivial severity in the majority (Tables 3 and 4). 
Decreased attenuation, as part of a mosaic attenuation pattern, was 
present in 43% of scans; 35 of the 36 scans with decreased attenua-
tion had >5% extent of the pattern (Figure 2). Bronchiectasis, lobar 
volume loss, and large- or small-airway plugging were seen in 33%, 
29%, and 26% respectively, and emphysema in 7%. Consolidation 
(2%), reticulation (1%), ground-glass opacification (1%), and pul-
monary air cysts (1%) were uncommon HRCT findings.
The extent of decreased attenuation, as a component of the 
mosaic attenuation pattern, was strongly correlated with the 
extent of bronchiectasis (rs  =  0.68; P  <  .001) and the severity 
of bronchial wall thickening (rs = 0.63; P <  .001). There were 
weaker associations between the extent of decreased attenua-
tion and plugging of large (rs = 0.40; P < .001) or small (rs = 0.38; 
P  <  .001) airways. The severity of bronchial wall thickening 
was also strongly correlated with the extent of bronchiectasis 
Enrolled (n = 202)
Complete CXR and clinical data (n = 193)
No CXR available
(n = 9)
Abnormal CXR with or without
fulfillment of
clinical case definition
(n = 84)
Fulfilling clinical case
definition; normal CXR
(n = 37)
Normal CXR and no abnormal
clinical findings (n = 72)
Desaturation on exercise
(n = 8)
Abnormal CXR only
(n = 40)
Normal CXR but abnormal
spirometry (n = 6)
Abnormal CXR + spirometry
(n = 13)
Normal CXR but chronic
cough (n = 6)
Abnormal CXR + chronic
cough (n = 4)
Normal CXR but MRC
dyspnea score score>2
(n = 4)
Abnormal CXR +
desaturation on exercise
(n = 4)
Abnormal CXR +
abnormal spirometry results,
O2 saturation <92%,
chronic cough, and/or
MRC dyspnea score >1
(n = 13)
Abnormal CXR +
abnormal spirometry results,
O2 saturation <92%,
chronic cough, and/or
MRC dyspnea score >1
(n = 23)
HRCT findings
Abnormal (n = 56)
Normal (n = 7)
Uninterpretable (n = 3)
No HRCT done (n = 18)
HRCT findings
Abnormal (n = 17)
Normal (n = 4)
Uninterpretable (n = 2)
No HRCT done (n = 14)
Figure 1. Flow chart of study participants. Abbreviations: CXR, chest radiography; HRCT, high-resolution computed tomography; MRC, Medical Research Council; O2, 
oxygen.
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(rs  =  0.61; P  <  .001) and with plugging of large (rs  =  0.49; 
P < .001) or small (rs = 0.50; P < .01) airways. Decreased atten-
uation and the extent of bronchiectasis were strongly correlated 
with FEV1 (rs = −0.52; P < .001 and rs = −0.50; P < .001 respec-
tively) (Table 5).
Observer variability for quantifying the extent of abnormal 
lung on chest radiographs was moderate (κω = 0.56) (Tables 6 
and 7). Observer agreement for semiquantitative HRCT abnor-
malities was moderate to good, and the single-determination 
SD for the 7 continuous HRCT variables ranged from 5.8% for 
consolidation to 31.0% for decreased attenuation.
DISCUSSION
Our study shows that there is a high prevalence of lung disease in HIV-
infected children receiving ART. The most common abnormality on 
plain chest radiographs were ring and tramline opacities, suggestive 
of airway inflammation. However, HRCT is the imaging modality of 
choice for the investigation of small- and large-airway disease. The 
principal HRCT abnormality were regions of decreased attenuation 
admixed with lung of normal density, the “mosaic attenuation pat-
tern.” Because of its lower contrast resolution, the mosaic pattern is 
not seen on chest radiographs. By contrast, HRCT is exquisitely sen-
sitive to any alteration in density, which, for the lung parenchyma, is 
strictly governed by the amount of air. Any change in the relative pro-
portion of air, whether this is physiological (as is seen during normal 
breathing) or pathological (as might occur with any infiltrative dis-
ease; with impaired ventilation caused by small-airway disease and 
specifically, obliterative bronchiolitis [OB]; or with altered perfusion 
[eg, chronic thromboembolic disease]), will increase or decrease 
parenchymal attenuation [20].
In our patients, there was no clinical evidence of an infiltra-
tive disease, such as infection of pulmonary edema. Moreover, 
the strong association between the extent of decreased attenua-
tion and indices of airflow obstruction (FEV1 and forced expir-
atory flow, midexpiratory phase), without reversibility, makes 
Table  2. Characteristics of Study Participants Undergoing Chest 
Radiography and High-Resolution Computed Tomographic
Characteristic
Participants, No. (%)a
Undergoing Chest 
Radiography 
(n = 193)
Undergoing 
HRCT
(n = 84)
Female sex 89 (46) 44 (52)
Age, median (IQR), y 11.2 (9.0–12.8) 11.6 (9.6–13.6)
Age at diagnosis, median (IQR), y 4.9 (2.7–7.5) 5.5 (3.3–8.5)
Duration of ART, median (IQR), y 4.8 (2.6–6.4) 4.7 (2.7–6.6)
CD4 cell count, median (IQR), cells/µL 720 (473–947) 686 (447–887)
HIV load <400 copies/mL 150 (79)b 64 (77)c
Any respiratory symptom 51 (26) 32 (38)
MRC dyspnea score >1 22 (11) 15 (18)
Daily cough for >1 mo 30 (16) 21 (25)
Daily cough for >1 mo with sputum 18 (12) 13 (15)
Wheezing 9 (5) 4 (5)
Household member who is a smoker 42 (22) 23 (27)
Height-for age z score ≤2 69 (36) 32 (38)
Weight-for age z score ≤2 18 (9) 9 (11)
Known history of asthma 7 (4) 2 (2)
History of Pneumocystis jirovecii 6 (3) 1 (1)
Previously treated for tuberculosis 74 (38) 34 (40)
Tachypnea (respiratory rate >30/min at 
rest for age 6–12 y or >24/min for 
age 13–16 y)
12 (6) 6 (7)
Abnormal SpO2 (resting hypoxia <92% 
or desaturation >5% with exercise)
23 (12) 15 (18)
Abnormal results of spirometryd 40 (24) 27 (37)
Obstructive pattern at spirometry 7 (5)e 5 (10)f
Chest radiograph identified as abnormal 
by respiratory physician
84 (43) …
Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; IQR, inter-
quartile range; MRC, Medical Research Council; SpO2, oxygen saturation.
aData represent No. (%) of participants unless otherwise specified.
bViral load data were missing in 3 participants. 
cViral load data were missing in 2 participants.
dSpirometric results were of acceptable quality for 127 participants in the chest radiography 
group and 73 in the HRCT subgroup.
eSpirometric data available in 136 individuals. 
fSpirometric data available in 51 individuals.
Table  3. Prevalence and Extent/Severity of High-Resolution Computed 
Tomographic Scan Abnormalities
HRCT Pattern
Participants, No. (%)
Prevalence 
of Pattern
Relative Proportion of Severitya 
0 < Score < 25 25 < Score < 50 Score ≥50
Bronchiectasis 
extent
28 (33) 19 (68) 8 (29) 1 (4)
Bronchiectasis 
severity
NA 17 (61) 9 (32) 2 (7)
Bronchial wall 
thickening
69 (82) 51 (74) 16 (23) 2 (3)
Small-airway 
plugging
12 (14) 12 (100) 0 (0) 0 (0)
Large-airway 
plugging
10 (12) 7 (70) 3 (30) 0 (0)
Lobar volume 
loss
24 (29) 22 (92) 1 (4) 1 (4)
Abbreviation: NA, not applicable.
aPercentage of total with pattern.
Table 4. Proportional Extent of High-Resolution Computed Tomographic 
Scan Patterns
HRCT Pattern
Participants, No. (%)
Prevalence of Pattern Pattern of >5% HRCT Extenta
Consolidation 2 (2) 2 (100)
Reticulation 1 (1) 1 (100)
Ground-glass opacity 1 (1) 1 (100)
Decreased attenuation 36 (43) 35 (97)
Emphysema 6 (7) 6 (100)
Air cysts 1 (1) 1 (100)
Cavitating nodules 0 (0) 0 (0)
Noncavitating nodules 0 (0) 0 (0)
aGiven as a percentage of those exhibiting the HRCT pattern.
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chronic thromboembolic disease highly unlikely and instead 
supports OB as the likely cause of chronic lung disease in HIV-
infected children. Importantly, there was a strong correlation 
between the extent of decreased attenuation and the extent 
of bronchiectasis, again strongly supporting airway-based 
pathology.
Histopathological [21] and CT studies [22] have shown that 
bronchiectasis and OB frequently coexist. Moreover, studies 
in which HRCT patterns have been correlated with functional 
indices have shown that OB may precede the onset of bron-
chiectasis, as opposed to the suppuration and dilatation of the 
large airways leading to OB [22, 23]. Notably, our finding that 
OB is the likely major abnormality accounting for chronic lung 
disease contrasts sharply with findings from the pre-ART era, 
when lymphoid interstitial pneumonitis was the most common 
cause of chronic lung disease in children [24]. Lymphoid inter-
stitial pneumonitis responds well to ART and corticosteroid 
treatment and is now uncommon [25].
It is important to appreciate that OB is not a diagnosis per 
se but a pathological lesion. Obliteration of the small airways 
(defined arbitrarily as those with an internal diameter <2 mm) 
is a common incidental pathological finding [26, 27]. The 
underlying mechanism is inflammation, which then causes 
partial or complete obliteration [28]. OB can occur as a sequel 
to diverse “insults,” including viral lower respiratory tract infec-
tions, connective tissue diseases, and exposure to toxic fumes, 
or as a manifestation of chronic graft-vs-host disease in recip-
ients of heart-lung transplants [28]. A biopsy might be con-
sidered the reference standard for diagnosis, but the lesions of 
OB are patchily distributed and without meticulous dissection; 
(compounded by issues of sampling error), the diagnosis is 
easily overlooked [29]. Furthermore, there is a high risk asso-
ciated with performing an open (surgical) biopsy in children 
with already compromised respiratory function, particularly in 
low-resource settings. 
Figure 2. A, Chest radiograph of a participant scored as normal independently by both radiologists. B, High-resolution computed tomographic (HRCT) scan of the same 
patient, through the midzone demonstrating a striking mosaic pattern with areas of decreased attenuation adjacent to regions of normal lung density. C, HRCT scan of another 
patient, again showing regions of decreased attenuation as part of the mosaic pattern with cylindrical bronchiectasis in the middle lobe.
Table  5. Correlation Between High-Resolution Computed Tomographic 
Patterns and Lung Function (Indices of Airflow Limitation)
HRCT abnormality
Association With Lung Function, Spearman Rank 
Correlation Coefficient, rs (P Value)
FEV1 FVC FEF25%–75% FEV1/ FVC
Bronchiectasis 
extent
−0.50 (<.001) −0.36 (.002) −0.44 (<.001) −0.26 (.03)
Bronchiectasis 
severity
−0.49 (<.001) −0.36 (.002) −0.44 (<.001) −0.26 (.03)
Bronchial wall 
thickening
−0.43 (<.001) −0.34 (.003) −0.34 (.003) NS
Small-airway 
plugging
−0.40 (<.001) −0.33 (.005) −0.37 (.01) NS
Large-airway 
plugging
−0.42 (<.001) −0.38 (.001) −0.36 (.002) NS
Volume loss −0.38 (.001) −0.34 (.003) NS NS
Decreased 
attenuation
−0.52 (<.001) −0.42 (<.001) −0.42 (<.001) NS
Abbreviations: FEF25%–75%, forced expiratory flow, mid-expiratory phase; FEV1, forced expi-
ratory volume in first second of expiration; FVC, forced vital capacity; NS, not significant.
Table 6. Interobserver Agreement for Evaluation of Radiological Patterns 
at Chest Radiography and High-Resolution Computed Tomographic: 
Continuous Variables
Pattern sdSD, %
Chest radiography
 Consolidation 19.7
 Ground-glass opacities 16.4
 Reticulation 1.0
 Noncavitating nodules 11.5
 Cavitating nodules 5.0
 Ring/tramline opacities 28.9
 Masses 0.0
HRCT 
 Overall extent 12.2
 Consolidation 5.8
 Ground-glass opacity 6.2
 Reticulation 5.6
 Decreased attenuation 31.0
 Emphysema 18.2
 Cysts 7.1
Abbreviations: NA, not applicable; sdSD, single-determination standard deviation.
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Chest radiography is widely available, of low cost, and has a rela-
tively low radiation dose, but it is an insensitive tool to identify OB: 
in our study, 56% of individuals with an abnormal HRCT scan had 
a normal chest radiograph. In addition, the 2-dimensional nature 
of the chest radiograph (leading to anatomic superimposition), and 
poor contrast resolution inevitably cause interpretative difficulties 
[30]. Therefore, HRCT coupled with lung function testing are 
probably the best noninvasive tests for a diagnosis of OB. 
However, owing to concerns about radiation dose, there is 
reluctance to perform HRCT studies in children. In addition, 
HRCT is not routinely available in resource-limited settings, 
which explains why this condition has not to date been iden-
tified in busy African HIV clinics. In the absence of alternative 
diagnoses, individuals with chronic symptoms are often treated 
presumptively for tuberculosis, a disease that is common in set-
tings with high HIV prevalence.
An interesting finding in our study was the presence of emphy-
sema (albeit of limited extent) in 7% of study participants. CT 
studies in a total of 1681 HIV-infected adults from 3 series [31–
33], have shown a prevalence of emphysema ranging from 19% 
to 53%. This large variation is, in part, almost certainly caused 
by different criteria for defining “significant” emphysema, and, 
even after controlling for smoking status, HIV was identified as 
an independent risk factor for emphysema [31].
There is a high reported prevalence of chronic lung disease, 
particularly airflow obstruction, among HIV-infected individu-
als, but mainly in high-income settings and among adults, where 
smoking and substance use is a major confounder. Importantly, 
none of the participants in our cohort had ever smoked, and 
biomass fuel use is relatively low in our setting, compared with 
other urban and periurban settings in sub-Saharan Africa [10, 
34, 35]. In addition, the prevalence of respiratory symptoms and 
poor lung function was substantially higher than in uninfected 
children of the same age group and socioeconomic status, as 
reported by Rylance et al [10]. The pathogenesis of chronic lung 
disease in HIV-infected children is not well understood but 
may be a long-term consequence of repeated respiratory tract 
infections or a direct consequence of HIV infection itself.
One strength of our study was that participants were not 
selected on the basis of symptoms. Subjects underwent HRCT 
scanning based on a predefined clinical case definition informed 
by previous studies that have shown a similar clinical picture in 
this age group [7]. In addition, radiological data was comple-
mented by detailed clinical and lung function data. Furthermore, 
all radiological studies were scored independently by 2 expe-
rienced thoracic radiologists. A limitation of the study was that 
HRCT was performed only in participants who had clinical fea-
tures of chronic lung disease or were assessed to have an abnormal 
chest radiograph, and some children with subclinical disease may 
have been missed, given the low sensitivity of chest radiography. 
HRCT scans were not available in 31% of participants. However, 
this was owing to participants not attending their scan appoint-
ments, and there was no difference in demographic or clinical fea-
tures between those who did and did not attend. We were unable 
to measure lung diffusion capacity. There was some interobserver 
variation in scoring HRCT scans and chest radiographs, but this is 
within the range expected and both radiologists reached consen-
sus on discrepant observations. It was not feasible to confirm our 
findings histologically. The study is cross-sectional, and therefore 
no causality can be attributed.
To our knowledge, ours is the first large prospective study of 
HRCT findings in HIV-infected older children and adolescents, 
and it demonstrated airway disease to be the major cause of 
chronic lung disease in this age group, in contrast to findings of 
lymphoid interstitial pneumonitis in the pre-ART era. Studies 
to elucidate the natural history and etiology are urgently needed 
so that therapeutic strategies can be developed.
Notes
Author contributions. J. M., K. K., and R. A. F. designed the study and 
undertook the literature search. S. R. D. and A. N. undertook quantification 
of chest radiographic and HRCT abnormalities. A. N. and J. R. analyzed the 
data (with input from S. R. D. and R. A. F.). G. M. and E. M. coordinated the 
study. H. M., K. N., and G. M. provided clinical care. H. M. and K. N. con-
tributed to the study design and study logistics. S. R. D. wrote the first draft 
of the manuscript. S. R. D. and R. A. F. had full access to all the data in the 
study and final responsibility for the decision to submit for publication. All 
authors contributed to writing the report and have approved the final draft.
Disclaimer. The funding sources had no role in the writing of the man-
uscript or in the decision to submit for publication.
Financial support. This work was supported by the Nina Ireland 
Program for Lung Health (J. M.) and the Wellcome Trust through an 
Intermediate Fellowship (grant 095878/Z/11Z to R. A. F.).
Potential conflicts of interest. All authors: No reported conflicts of 
interest. All authors have submitted the ICMJE Form for Disclosure of 
Potential Conflicts of Interest. Conflicts that the editors consider relevant to 
the content of the manuscript have been disclosed.
References
1. UNAIDS. 2015 Progress report on the global plan towards the elimination of new 
HIV infections among children and keeping their mothers alive. Available at: http://
www.who.int/woman_child_accountability/ierg/reports/UNAIDS_Progress 
ReportGlobalPlan_FINAL_July17_Web.pdf. Accessed 1 August 2017.
Table 7. Interobserver Agreement for Evaluation of Radiological Patterns 
at Chest Radiograph and High-Resolution Computed Tomographic: Ordinal 
Variables
Pattern κω
Chest radiography
 Overall extent 0.56
 Paucity of vessels NA
 Hilar/mediastinal nodes NA
 Volume loss NA
HRCT 
 Bronchiectasis extent 0.66
 Bronchiectasis severity 0.68
 Bronchial wall thickening 0.60
 Small-airway plugging 0.59
 Large-airway plugging 0.81
 Volume loss 0.64
Abbreviations: NA, not applicable.
Downloaded from https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/cix778/4103341
by London School of Hygiene & Tropical Medicine user
on 27 November 2017
8 • CID 2017:XX (XX XXXX) • Desai et al
2. Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand 
RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a 
review of emerging challenges. Lancet Infect Dis 2014; 14:627–39.
3. Davies MA, Gibb D, Turkova A. Survival of HIV-1 vertically infected children. 
Curr Opin HIV AIDS 2016; 11:455–64.
4. Crook AM, Turkova A, Musiime V, et al. Tuberculosis incidence is high in HIV-
infected African children but is reduced by co-trimoxazole and time on antiretro-
viral therapy. BMC Med 2016; 14:50.
5. Mwalukomo T, Rylance SJ, Webb EL, et al. Clinical characteristics and lung func-
tion in older children vertically infected with human immunodeficiency virus in 
Malawi. J Pediatric Infect Dis Soc 2016; 5:161–9.
6. Githinji LN, Gray DM, Hlengwa S, Myer L, Zar HJ. Lung function in South 
African adolescents infected perinatally with HIV and treated long-term with 
antiretroviral therapy. Ann Am Thorac Soc 2017; 14:722–9.
7. Ferrand RA, Desai SR, Hopkins C, et al. Chronic lung disease in adolescents with 
delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis 2012; 
55:145–52.
8. Attia EF, Weiss NS, Maleche Obimbo E, et al. Risk factors for hypoxia and tachyp-
nea among adolescents with vertically-acquired HIV in Nairobi. Pediatr Infect 
Dis J 2017; 36:e93–7.
9. Rylance J, Meghji J, Miller RF, Ferrand RA. Global considerations in human 
immunodeficiency virus-associated respiratory disease. Semin Respir Crit Care 
Med 2016; 37:166–80.
10. Rylance J, Mchugh G, Metcalfe J, et al. Chronic lung disease in HIV-infected chil-
dren established on antiretroviral therapy. AIDS 2016; 30:2795–803.
11. Miller MR, Hankinson J, Brusasco V, et al.; ATS/ERS Task Force. Standardisation 
of spirometry. Eur Respir J 2005; 26:319–38.
12. Quanjer PH, Stanojevic S, Cole TJ, et al.; ERS Global Lung Function Initiative. 
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global 
lung function 2012 equations: report of the Global Lung Function Initiative 
(GLI), ERS task force to establish improved lung function reference values. Eur 
Respir J 2012; 40:1324–43.
13. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. 
Fleischner society: glossary of terms for thoracic imaging. Radiology 2008; 
246:697–722.
14. Desai SR, Copley SJ, Barker RD, et al. Chest radiography patterns in 75 adoles-
cents with vertically-acquired human immunodeficiency virus (HIV) infection. 
Clin Radiol 2011; 66:257–63.
15. Hansell DM, Rubens MB, Padley SP, Wells AU. Obliterative bronchiolitis: individ-
ual CT signs of small airways disease and functional correlation. Radiology 1997; 
203:721–6.
16. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: 
correlation between computed tomography features and pulmonary function 
tests. Thorax 2000; 55:198–204.
17. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development 
of a WHO growth reference for school-aged children and adolescents. Bull World 
Health Organ 2007; 85:660–7.
18. Dowson LJ, Guest PJ, Hill SL, Holder RL, Stockley RA. High-resolution computed 
tomography scanning in α1-antitrypsin deficiency: relationship to lung function 
and health status. Eur Respir J 2001; 17:1097–104.
19. Brennan P, Silman A. Statistical methods for assessing observer variability in clin-
ical measures. BMJ 1992; 304:1491–4.
20. Worthy SA, Müller NL, Hartman TE, Swensen SJ, Padley SP, Hansell DM. Mosaic 
attenuation pattern on thin-section CT scans of the lung: differentiation among infil-
trative lung, airway, and vascular diseases as a cause. Radiology 1997; 205:465–70.
21. Kang EY, Miller RR, Müller NL. Bronchiectasis: comparison of preoperative 
thin-section CT and pathologic findings in resected specimens. Radiology 1995; 
195:649–54.
22. Hansell DM, Wells AU, Rubens MB, Cole PJ. Bronchiectasis: functional sig-
nificance of areas of decreased attenuation at expiratory CT. Radiology 1994; 
193:369–74.
23. Barker AF, Bardana EJ Jr. Bronchiectasis: update of an orphan disease. Am Rev 
Respir Dis 1988; 137:969–78.
24. Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent 
and chronic lung disease in HIV-1 infected and uninfected African children. 
AIDS 1998; 12:1185–93.
25. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other 
infections in HIV-infected children in the HAART era. JAMA 2006; 296:292–300.
26. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in 
chronic obstructive lung disease. N Engl J Med 1968; 278:1355–60.
27. McLean KH. The pathology of acute bronchiolitis; a study of its evolution. II. The 
repair phase. Australas Ann Med 1957; 6:29–43.
28. King TE Jr. Bronchiolitis. In: Schwarz MI, King TE Jr, eds. Interstitial lung dis-
eases. 3rd ed. Hamilton, Ontario, Canada: BC Decker; 1998:645–84.
29. Geddes DM, Corrin B, Brewerton DA, Davies RJ, Turner-Warwick M. Progressive 
airway obliteration in adults and its association with rheumatoid disease. Q J Med 
1977; 46:427–44.
30. Coblentz CL, Babcook CJ, Alton D, Riley BJ, Norman G. Observer variation in 
detecting the radiologic features associated with bronchiolitis. Invest Radiol 1991; 
26:115–8.
31. Attia EF, Akgün KM, Wongtrakool C, et al. Increased risk of radiographic emphy-
sema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest 
2014; 146:1543–53.
32. Guaraldi G, Besutti G, Scaglioni R, et al. The burden of image based emphysema 
and bronchiolitis in HIV-infected individuals on antiretroviral therapy. PLoS One 
2014; 9:e109027.
33. Clausen E, Wittman C, Gingo M, et  al. Chest computed tomography findings 
in HIV-infected individuals in the era of antiretroviral therapy. PLoS One 2014; 
9:e112237.
34. Piddock KC, Gordon SB, Ngwira A, et al. A cross-sectional study of household 
biomass fuel use among a periurban population in Malawi. Ann Am Thorac Soc 
2014; 11:915–24.
35. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollu-
tion in low and middle income countries. Lancet Respir Med 2014; 2:823–60.
Downloaded from https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/cix778/4103341
by London School of Hygiene & Tropical Medicine user
on 27 November 2017
